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Abstract 
Membrane proteins make up a diverse and important subset of proteins for which 
structural information is limited. In this study, chemical cross-linking and mass 
spectrometry were used to explore the structure of the G-protein-coupled photoreceptor 
bovine rhodopsin in the dark-state conformation. All experiments were performed in rod 
outer segment membranes using amino acid "handles" in the native protein sequence and 
thus minimizing perturbations to the native protein structure. Cysteine and lysine 
residues were covalently cross-linked using commercially available reagents with a range 
of linker arm lengths. Following chemical digestion of cross-linked protein, cross-linked 
peptides were identified by accurate mass measurement using liquid chromatography- 
fourier transform mass spectrometry and an automated data analysis pipeline. 
Assignments were confirmed and, if necessary, resolved, by tandem MS. The relative 
reactivity of lysine residues participating in cross-links was evaluated by labeling with 
NHS-esters. A distinct pattern of cross-link formation within the C-terminal domain, and 
between loop I and the C-terminal domain, emerged. Theoretical distances based on 
cross-linking were compared to inter-atomic distances determined from the energy- 
minimized X-ray crystal structure and Monte Carlo conformational search procedures. In 
general, the observed cross-links can be explained by re-positioning participating side- 
chains without significantly altering backbone structure. One exception, between C3 16 
and K325, requires backbone motion to bring the reactive atoms into sufficient proximity 
for cross-linking. Evidence from other studies suggests that residues around K325 for a 
region of high backbone mobility. These findings show that cross-linking studies can 
provide insight into the structural dynamics of membrane proteins in their native 
environment. 
Keywords: bovine rhodopsin, chemical cross-linking, Q-Tof, FT-IC& tandem mass 
spectrometry 
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Section I: Chemical Cross-linking and 
Mass Spectrometry Applied to 
Determination of Bovine Rhodopsin 
Structure and Dynamics 
Mobility in the C-terminal region of dark-state bovine rhodopsin 
revealed by chemical cross-linking and high-resolution mass 
spectrometry. 
Abbeviations 
MS, mass spectrometry; FTICR, fourier transform infra-red coupled resonance; Q-Tof, 
quadrapole time-of-flight; LC-MS, liquid chromatography - mass spectrometry; MSMS, 
tandem mass spectrometry; CID, collision-induced dissociation; ECD, electron capture 
dissociation; ROS, rod outer segment; HPLC, high-pressure liquid chromatography; 
TFA, trifuoroacetic acid; ACN, acetonitrile; TCEP, tris (2-carboxyethyl) phosphine; 
NHS, N-hydroxysuccinimide, MD, molecular dynamics; ALS, ammonium lauryl sulfate; 
BME, P-mercaptoethanol 
Introduction 
Recent advances in genomic and proteomic approaches to identifying novel proteins 
highlight a need for methods of evaluating the structure and conformational dynamics of 
proteins and protein complexes. Membrane proteins, encoded by -20% of the genes in 
most organisms, play a central role in intracellular signaling, energy and material 
transport, cell intoxication and pathogenesis, and cell recognition and motility. However, 
relative to soluble proteins few membrane protein structures have been resolved by X-ray 
crystallography andor NMR spectroscopy.(l) Progress in the structural analysis of 
eukaryotic membrane proteins in particular has been slowed by the instability of these 
proteins in environments lacking phospholipids, their tendency toward aggregation and 
precipitation, low protein abundance, difficulties in expressing functional protein, and 
sample purity issues which have hindered the application of standard structural 
determination methods. 
Such technical challenges have necessitated the use of a variety of techniques to gather 
information about the structure and conformational dynamics of membrane proteins. 
Disulfide mapping, photoaffinity labeling, metal-ion binding, solvent accessibility, and 
site-directed spin labeling studies combined with electron paramagnetic resonance 
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(SDSL-EPR) have been used to obtain low to moderate resolution distance constraints in 
membrane proteins.(2-12) These methods typically require the construction and 
expression of site-specific histidine or cysteine mutants of the native protein. Several 
groups have recently reported an approach to the analysis of protein structure which 
combines chemical cross-linking, mass spectrometry, and computer modeling to obtain 
moderate-resolution structural information (13-1 6). Chemical cross-linking utilizing the 
amino acid ‘handles’ available in the native protein sequence offers the advantage of 
minimally perturbing protein structure and allowing studies to be carried out in the native 
membranes . 
We chose the intensively studied G-protein-coupled receptor (GPCR) rhodopsin as a 
model system for developing a cross-linking methodology for membrane proteins. 
Bovine rhodopsin has the major advantages that it can be purified in large quantities in its 
native rod outer segment (ROS) membrane and it has a known crystal structure 
(1 7)against which we can validate our results. The study of native membrane proteins by 
chemical cross-linking requires significant optimization of a) sample preparation methods 
(including reaction conditions, separation of monomeric protein, and proteolysis), b) LC- 
MS conditions for separating and identifying complex mixtures of hydrophobic peptides, 
and c) data analysis software for the assignment of complex MS spectra. We show that 
the specific sites of cross-linking in bovine rhodopsin can be identified using this 
strategy. 
We also considered the best way to relate the formation of inter-residue cross-links to 
the structure and dynamics of a protein, an issue that has great impact on the utility of 
cross-linking data in structure determination. In principal, upper bounds on the distance 
of closest approach (DCA) between the involved atoms can be inferred from the 
formation of the cross-link, provided the cross-linking reaction does not somehow distort 
the protein structure. Considered in isolation, flexible cross-links between atoms on 
flexible amino acid side chains produce constraints with large distance uncertainties, 
limiting the accuracy of structural models which depend on them, whether the protein is 
soluble(l6) or a membrane protein.(18) An alternative approach is to perform a series of 
cross-linking reactions with several reagents with nested lengths and identical end-group 
reactivity and determine whether there is a minimum length that allows for the formation 
of the cross-link.(l9) This approach sets upper and lower bounds on the DCA between 
the two tethered atoms, potentially resulting in a distance measurement associated with a 
small uncertainty (-1 -2 A), albeit a measurement of the dynamic DCA between two 
atoms that is achieved over a time scale of minutes. This approach is similar to the use of 
nested-length covalently-tethered inhibitors on transmembrane channels as molecular 
“tape measures’’ to measure the radial distance of residues from the pore.(20) In order to 
validate chemical cross-linking as a method for deriving bounds on inter-residue 
distances, we have extensively compared experimentally observed cross-links in bovine 
rhodopsin with those predicted from the known structure of the protein using a variety of 
modeling approaches. As a baseline, we compared cross-link derived distances to the 
side-chain distances determined from the energy minimized X-ray crystal structure.(17) 
The crystal structure, however, represents a single static conformation of rhodopsin, and 
therefore conformational search procedures and the results of a 40 ns molecular dynamics 
simulation(21) were also used to identify side-chain and/or backbone dynamics that could 
lead to the observed cross-links. 
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In general, the observed cross-links are consistent with the structural information 
available for bovine rhodospin when evaluated using the modeling techniques described 
above, although the data implies significant side-chain motion relative to the crystal 
structure coordinates. The results indicate that cross-linking is a useful technique for 
probing membrane structure and, in particular, assessing the dynamic features of a 
structure - features that may be important in the conformational changes that accompany 
protein activation and protein-protein interactions. 
Experimental Procedures 
Materials 
Frozen bovine retinas were purchased from Schenk Packing Company, Inc. (Stanwood, 
WA). Tris(2-carboxyethyl) phosphine hydrochloride (TCEP-HCl), and the cross-linking 
reagents, including disuccinimidyl tartarate (DST), disuccinimidyl glutarate (DSG), 
disuccinimidyl suberate (DSS), N-(y-Maleimidobutyryloxy) succinimide ester (GMBS), 
N-E-Maleimidocaproyloxy]succinimide ester (EMCS), succinimidyl4-[N- 
maleimidomethyl] cyclohexane- 1 -carboxy-(6-amidocaproate) (LC-SMCC), and N- 
Succinimidyl iodoacetate (SIA), were obtained from Pierce Biotechnology, Inc. 
(Rockford, IL). Dimethyl sulfoxide (DMSO), N-(2-Hydroxyethyl)piperazine-N'-(2- 
ethanesulfonic acid) (HEPES), 4-vinyl-pyridine, trifluoroacetic acid (TFA), ammonium 
lauryl sulfate (ALS), and cyanogen bromide (CNBr), were purchased from Sigma- 
Aldrich (St. Louis, MO). The detergent, n-Nonyl-P-D-glucoside, was purchased from 
Anatrace, Inc. (Maumee, OH). N-hydroxysuccinimidyl acetate (NHS-Ac), was 
purchased from ICN Biomedical (Irvine, CA). 
prepared under dim red light (> 650 nm) as previously described.(22) Briefly, ROS 
fragments were isolated using the sucrose flotation method.(23) and purified via a 
sucrose step gradient centrifugation. ROS membranes were washed with hypotonic 
buffer (1 0 mM HEPES, 1 mM DTT, 100 pM EDTA, and 100 pM PMSF) to remove 
loosely bound polypeptides and subsequently stored in isotonic buffer (1 00 mM NaC1, 10 
mM HEPES, 5 mM MgC12.6H20, 1 mM DTT, and 100 pM PMSF) at -80°C until 
needed. 
Rhodopsin quantification. Extraction of rhodopsin from purified ROS membranes 
was achieved by centrifugation (16,000 g, 5 min) and subsequent resuspension in 50 mM 
pyridine-HC1 (pH 6.5) with 25 mM ZnCl2 and 0.6% n-nonyl-P-D-glucoside.(24) Samples 
were incubated at room temperature for 30 min. to solubilize, and the concentration of 
rhodopsin was determined based on the absorbance difference at 500 nm before and after 
illumination (E  = 42,700 M-' crn-l).(25) 
Cross-linking. All reactions were performed under dim red light unless otherwise 
indicated. Lysine-lysine cross-linkers were DST, DSG, DSS; cysteine-lysine cross- 
linkers were SIA, GMBS, EMCS, and LC-SMCC (refer to the Supplemental Section for 
cross-linker chemical structures). Stock solutions were prepared by dissolving cross- 
linkers in DMSO at a concentration of 300 mM. Lysine-lysine cross-linking was 
performed on rhodopsin in purified ROS membranes (10 pM rhodopsin) in 50 mM 
ROS membrane purification. Rod outer segments (ROS) from bovine retinas were 
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HEPES buffer, with 100 mM NaC1, pH 7.5, containing 10-200 fold molar excess of 
cross-linker. The reaction was performed at 37°C for 30 min, and quenched with 10 mM 
Tris, pH 7.5, for 15 min. at room temperature. Cysteine-lysine cross-linking was carried 
out in two steps. In the first step, cysteine coupling was favored by incubating cross- 
linker (typically at 200-fold molar excess over rhodopsin for 30 min. at 37°C) and ROS 
at low pH (50 mM pyridine, 100 mM NaC1, pH 6). The membrane was then pelleted and 
washed to remove unreacted cross-linker and incubated in 50 mM HEPES,100 mM NaC1, 
pH 7.5 for one hour to facilitate the reaction of cysteine-bound cross-linker with lysine 
residues. Samples were quenched with 10 mM Tris-HC1, pH 7.5 and 0.01% p- 
mercap toethanol (BME). 
Disulfides were reduced with 50 mM tris(2-carboxyethy1)phosphine (TCEP) in 50 mM 
HEPES buffer, 100 mM NaC1, pH 7.5, for 30 min. at 37°C. Samples were alkylated with 
150 mM 4-vinylpyridine(26) at room temperature for 30 min and washed several times 
using the same buffer to remove the 4-vinylpyridine. 
Monomer purification and cleavage with CNBr. Monomeric rhodopsin was 
separated from multimeric cross-linked protein and contaminants by preparative tris- 
glycine ALS-PAGE using a mini-prep cell (Bio-Rad) containing a column gel (1 1 % 
acrylamide resolving gel (5  cm long), 4 % acrylamide stacking gel (4 cm long), 1 cm 
diameter) equipped with a peristaltic pump and a fraction collector. Eluted protein 
fractions were collected and analyzed by SDS-PAGE and Coomassie staining, and 
fractions containing monomeric rhodopsin were pooled and concentrated using 
centrifugal filters (5-  1 OK MWCO, Millipore). Purified rhodopsin was subsequently de- 
lipidated by chloroform/methanol/water extraction (2 7), and the resulting pellets were 
washed once with acetone before being solubilized for CNBr digestion. Failure to 
remove methanol by acetone wash following extraction resulted in substantial 
methylation of the protein. A stock solution of high purity (>99%) CNBr in acetonitrile 
(4M) was prepared. Rhodopsin samples were first dissolved in 100% TFA, diluted to 
70% TFA with water, and then chemically digested with 100-200 mM CNBr. Generally, 
sample vials were flushed with nitrogen, covered with aluminum foil and shaken 
overnight at room temperature, although equivalent results were seen after 6 hrs of 
incubation. Digested samples were dried and washed once with acetonitrile to remove 
the residual TFA and CNBr. Dried samples were stored at -80°C until further analysis. 
Lysine labeling and double digest. ROS membrane was pelleted and resuspended in 
50mM pyridine, l O O m M  NaC1, pH 7 to a final rhodopsin concentration of 10 mM. For 
cysteine labeling, ROS membrane was incubated with 50 - 1000-fold excess of N-ethyl 
maleimide for 60 minutes at 37°C and quenched with 0.01 % BME. For lysine labeling, 
ROS membrane was incubated with a 50-fold (for straight labeling experiments) or 200- 
fold (for “pulse-chase” experiments) molar excess of NHS-acetate or NHS-propionate at 
37°C for 60 minutes. For pulse-chase experiments, a 5600-fold molar excess of the 
appropriate NHS-ester was then added for 60 min. to acetylate unreacted lysines. 
Reactions were quenched with 1 O O m M  Tris, pH 7. Membrane was next washed twice 
with lOOmM Ethyl Morpholine Acetate, pH 8.03 and resuspended to a rhodopsin 
concentration of 1 mg / mL in the same buffer with 5 % ACN and 0.01 % p- 
mercapthoethanol (by vol.) for digestion with trypsin. Then, 1 :5 Trypsin was added to an 
enzyme:rhodopsin ratio of 1 :5 (Typsin Gold Mass Spect Grade, Promega) and incubated 
Prior to delipidation and digestion, cysteine residues were reduced and alkylated. 
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at 60°C overnight (1 6 - 24 hours). Trypsin was added again at an enzyme:rhodopsin 
ratio of 1 : 10 and the samples were incubated at 37°C for another 3 hrs. The samples 
were washed once with 50mM pyridine, lOOmM NaC1, pH 7 to remove trypsin, reduced 
and alkylated, and processed by CMW extraction and CNBr digestion, as described 
above. 
an equal volume of ACN and then water to a final ratio of 10: 10:80 by volume. The 
typical concentration, based on quantification before CMW extraction, was 0.5-1 
mg/mL. A portion (5-10 p1) was loaded onto a polysterene/divinylbenzene column 
(PLRP/S, 0.2x150mm, Michrom Bioresources, Auburn, CA) and separated using buffer 
and gradient conditions as follows: buffer A, 5% acetic acid, 2.5% ACN and 2.5% 
isopropanol; buffer B, 4% acetic acid, 40% ACN and 50% isopropanol; gradient (in % B 
buffer), 0 for 1 min, 0-15% in 4 min, 15-60 in 30 min, 60-100 in 15 min; flow rate, 5 
pl/min. All chromatographic separations were performed at 25°C using an Agilent 1100 
capillary HPLC system (Agilent Technologies, Palo Alto, CA). The column was 
connected directly to the mass spectrometer with no split. 
Mass spectrometry was performed using an APEX I1 FTMS equipped with a 7.0 T 
superconducting magnet and an Apollo ESI ion source (Bruker Daltonics, Billerica, MA), 
upgraded with a mass selective quadrupole front end. Mass spectra were obtained by 
accumulating ions in the ESI source hexapole and running the quadrupole mass filter in 
non mass-selective RF-only mode so that ions of a broad m/z range (300-2000) were 
passed to the FTMS analyzer cell. All spectra were acquired in positive ion mode. 
Preparative liquid chromatography and MS/MS. Preparative LC separation was 
performed on a Hewlett Packard 1100 series LC. The LC system was outfitted with a 
quaternary pump, a DAD (Diode Array Detector), an autosampler, and an in-line mobile 
phase vacuum degasser. Samples were purified using a Michrom BioResources, Inc. 
PLRP-S column (5p particle size, 300 8,2.0x150mm) at 30°C. The gradient was (in % B 
buffer, see LC-MS section for description of buffers): 0-20 in 5 min, 20-70 in 50 min, 70- 
100 in 10 min. The flow rate was 0.25-0.3 mL/min. The samples were prepared by re- 
suspending the dried CNBr digested pellet with TFA or formic acid and diluting to 10 % 
with buffer A (final vol. 400 pl or less). A typical prep used 200-400 pg of starting 
material (based on quantification of rhodopsin in ROS membrane) for a final 
concentration of ca. 1 mg/ml or less. The effluent fractions were collected using a Bio- 
Rad 2 1 10 fraction collector and their mass spectra were analyzed by direction infusion on 
an ESI-Q-Tof mass spectrometer (Micromass Ultima API, Waters) in order to determine 
the fractions containing the desired cross-linked species. MS/MS analysis was performed 
on the purified cross-linked peptides by either ESI-FT-MS (Apex 11, Bruker Daltonics) or 
ESI-Q-Tof-MS (Micromass, Waters). For the former, mass spectra were obtained by 
accumulating ions in the ESI source hexapole and running the quadrupole mass filter in 
non-mass-selective RF-only mode so that ions of a broad m/z range (300-2000) were 
passed to the FTMS analyzer cell. After the precursor ion was isolated from the mixture 
by setting the quadrupole mass filter to pass the m/z of interest, the MS/MS spectra were 
obtained by dropping the entrance to the collision hexapole to approximately -20 V. All 
spectra were acquired in positive ion mode. 
For MS/MS using Q-Tof-MS, direct infusion of LC fractions was at 1 pl/min. The 
most abundant charge state was fragmented at collision energies ranging from 16 to 65 
LC-MS. Rhosopsin CNBr digest products were dissolved in formic acid, diluted with 
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depending on the charge state, size and fragmentation pattern of the cross-linked 
peptides. Scans of one second duration were collected for up to 60 minutes in the case of 
low-abundance cross-links. The largest cross-linked peptides and any cross-link 
containing peptide 50 - 86 were most effectively be analyzed by ECD using FT-MS 
because of the high resolution necessary to resolve complex mixtures of large fragments 
in the former case and the difficulty of fragmenting between two adjacent lysine residues 
in the center of peptide 50 - 86 in the latter case. 
Data analysis. Reduction of MS spectra is automated by a macro developed in our 
laboratory and implemented within the Xmass software package (Bruker Daltonics) as 
described previously.(28) For all MS scans during an LC-MS experiment, the data 
reduction macro de-convolutes a list of m/z values into a single set of monoisotopic 
masses. The program output includes the monoisotopic mass, the observed charge states 
and corresponding m/z values, the relative abundance of the most abundant isotope peak 
for that mass, and an indicator of the certainty the observed mass is the monoisotopic 
mass. The list of monoisotopic masses are then matched to a theoretical library of cross- 
modified andor unmodified proteolysis products generated by the program ASAP 
(Automated Spectrum Assignment Program), described previously ( I  6). ASAP accepts 
user input on protein sequence, amino acid modifications, cross-linker specificities, 
proteolytic method, and mass error limits to generate a theoretical library and assign 
observed masses. 
Tandem MS data was analyzed using the in-house program MS2Links, an updated 
software version of MS2Assign described previously.(29) MS2Assign and MS2Links 
were developed for the assignment of tandem mass spectra of unmodified, labeled, andor 
cross-linked peptides on the same principle as ASAP (described above). The program 
generates a theoretical library of expected tandem MS fragments, accepting the same 
protein modifications as ASAP and considering a, b, c, x, y, z, internal, and immonium 
ions, and additional loss of H20, NH3, CO, and C02. Web based versions of ASAP and 
MS2Assign are available at http://roswell.ca.sandia.gov/-mmyoung. 
Molecular modeling methods 
Maximum cross-linker length. A 3-D structure of the cross-linker was constructed 
using Chem3D.(30) The bond torsion angles in the molecule were varied to find the 
combination of torsions that resulted in the longest distance between the reactive groups 
on the cross-linker (referred to as the "maximum cross-linker length"). The resulting 
structure was optimized using MM3(31-33) as implemented in Chem3D to ensure that 
the molecule was at an energy minimum. If the resulting structure was not hlly 
extended, the bond torsions were adjusted again to find the maximum cross-linker length 
for the optimized bond lengths and angles. The length of the MM3 optimized structure 
was generally within 0.1 8, of the maximum cross-linker length as described above. 
Rhodopsin structure. The A chain of the bovine rhodopsin crystal structure (lF88.pdb) 
was used as the starting structure for all comparisons to experimental distances. Missing 
atoms were modeled using the internal coordinates tables in the CHARMM22 topology 
definitions file. Energy calculations were performed using the CHARMM22 all atom 
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force field.(34, 35) Both the CHARMM(34) and NAMD(36) molecular mechanics 
packages were used for energy minimization and conformational search. 
Molecular dynamics trajectory. Paul Crozier kindly provided the results of a 40 ns 
molecular dynamics simulation of dark-adapted rhodopsin in an explicit lipid bilayer.(21) 
We sampled this MD trajectory every 20 ps to produce a more manageable trajectory of 
2000 structures from which structural data was extracted. 
Conformational search. Conformational searching was performed using a Monte 
Carlo sampling procedure in which 1 ps bursts of high-temperature molecular dynamics 
were used to randomize structure. Each Ips burst of MD was followed by energy 
minimization using the conjugate gradients algorithm to relax the structure into the 
nearest local minimum. Monte Carlo sampling was performed at both 500" K and 750" 
K and 1000 structures were generated at each temperature. In order to determine whether 
side-chain reorientations were sufficient to account for the experimental cross-links, 
conformational searches were done with a fixed backbone. A script, written and run in 
NAMD, was used for this sampling procedure. 
Constrained minimization. Constraints between cross-linked atoms were added to 
the CHARMM energy using the NOE constraints function built into CHARMM, which 
models distance constraints as a soft square well potential: 
where q is the distance between atom i and atomj, rl and r, are the lower and upper 
bounds on the distance, respectively, and kdist is a force constant, which was set to 10 
kcal/mold A2. The well-width was defined with an upper bound on the cross-linker 
length as described earlier. The lower bound was set equal to the sum of the van der 
Waals radii of the two cross-linked atoms. 
Constrained energy minimization was performed in three steps. In the first step, the 
structure was minimized with the distance constraint active and all non-bond interactions 
turned off. This allowed the side-chains to move freely within the structure to satisfy the 
distance constraint. In step two, non-bond interactions were turned on and the structure 
minimized to relieve bad contacts generated by the first minimization. In the final 
minimization the distance constraint was turned off to allow complete relaxation of the 
side-chains in their new local environment. 
Solvent accessibility. The COOR SURF command in CHARMM was used to compute 
the solvent accessible surface area (SASA) of rhodopsin for each 20 ps time-step of the 
molecular dynamics trajectory. The COOR SURF command in CHARMM computes the 
SASA using the Lee and Richards methods.(37) A probe radius of 1.4 8, was used for all 
SASA calculations. 
Results 
Sample preparation. Integral membrane proteins pose a significant analytical 
challenge due to their amphiphilic nature and their tendency to aggregate and adhere to 
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glass, plastic, and commonly used HPLC stationary phases. However, recent progress 
has been made in the preparation of integral membrane proteins, including rhodopsin, for 
mass spectrometry (38-45). In this work, methods were developed to maximize the 
recovery of cross-linked rhodopsin proteolysis products for subsequent LC-MS and 
tandem MS analysis. 
Bovine rhodopsin in the rod outer segment (ROS) membrane was first treated with 
either a cysteine-lysine (C-K) or lysine-lysine (K-K) cross-linking reagent under dim red 
light. The hetero-bifunctional C-K reagents chosen have a primary-amine reactive N- 
hydroxysuccinimide (NHS) ester group on one end and a sulfhydryl-reactive group 
(iodoalkyl for SIA, maleimide for all others) on the other and a range of linker arm 
lengths (refer to the Materials section for the definition of cross-linker abbreviations and 
the Supplemental section for chemical structures). The homobifunctional K-K reagents 
used have NHS ester groups at both ends and also have a range of linker lengths. 
During the cross-linking reaction, the cross-linker can react with two amino acid 
residues on single protein or between residues on different proteins to form a covalent 
dimer. Similarly, dimers can be linked to other rhodopsin molecules to form multimeric 
reaction products. All of these scenarios are indeed observed under the reaction 
conditions we used (Figure la). The molar excess of cross-linker to protein was 
optimized (typically 50: 1) in order to minimize the formation of multimeric protein. 
However, separation of monomeric and multimeric protein was necessary to ensure that 
only intra-molecular cross-links were being identified. Separation was achieved by 
preparative tube gel electrophoresis and fractionation. Fractions containing monomeric 
rhodopsin were pooled and concentrated (Figure lb), and detergent and residual lipids 
were then removed from the protein by chlorofonn/methanol/water (CMW) phase 
separation.(27) The pellet was then repeatedly washed with acetone (to avoid 
methylation due to residual methanol on the pellet) prior to being dissolved in 70% 
trifluoroacetic and subjected to CNBr cleavage. 
LC-MS. The total ion chromatogram (TIC) of the reverse phase HPLC separation and 
ESI-MS of CNBr digested rhodopsin is shown in Figure 2. For each sample, a consistent 
and reproducible cleavage pattern was observed following treatment with CNBr, 
facilitating the mass spectral analysis and assignment of the rhodopsin peptide fragments 
(Figure 2a). Several groups have reported the use of C4, C8 or C 18 columns for the RP- 
HPLC separation of digested peptides from integral membrane proteins including 
rhodopsin.(ll, 42) We achieved optimal separation using a polysterene/divinylbenzene 
column (PLRP-S, Michrom Bioresources) for the detection of hydrophobic and cross- 
linked rhodopsin fragments following CNBr cleavage. Using the LC-MS methods 
described in the Experimental section, 99% sequence coverage was obtained, not 
including the single methionine residues 1 and 309. Post-translational modifications of 
rhodopsin were also observed, including the glycosylation of peptide 2-39 and the 
palmitoylation of peptide 3 18-348. The retinal chromophore attached to Lys 296 and the 
disulfide bridge between Cys 1 10 and Cys 187, were not observed due to sample 
preparation conditions. Figure 2b illustrates the total ion chromatogram of EMCS cross- 
linked rhodopsin, with unique peaks due to the presence of un-modified peptides, singly 
modified peptides (i.e. “hanging” cross-linkers formed by the reaction of EMCS with a 
single residue within the peptide), internally cross-linked peptides, and cross-linked 
peptide pairs. It is important to note that, due to their lower concentrations, the selected 
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ion chromatograms (SICs) of cross-linked products (e.g. Figure 2d, 50-86x3 10-3 17) are 
typically of much lower intensity than the SICs of precursor peptides (e.g. Figure 2c, 50- 
86), making optimized sample recovery, chromatographic separation, and instrument 
sensitivity key factors in the detection of cross-linked species. 
Identification of Cross-Linked Products 
Criteria for identification. The fundamental basis for the MS3-D method is the 
identification of inter-residue chemical cross-links from which distance constraints are 
derived.(46, 47) We found it necessary to develop stringent guidelines for the 
identification of cross-linked peptides to rule out spurious assignments. From the present 
work, we determined that reliable identification of cross-linked peptides by mass 
spectrometry requires 1) reproducible chemical or enzymatic cleavage of the protein, 
thereby providing a consistent pattern of control peptides, 2) complete, or at least 
uniformly reproducible, sequence coverage in the control LC-MS spectra, 3) the presence 
of peaks corresponding to putative cross-linked species only in the LC-MS spectrum of 
the cross-linked sample and not in the control spectra, 4) the assignment of MS and 
tandem MS spectra to within a low experimental mass error (A ppm), and 5) the detection 
of mass-shifted peaks corresponding to cross-linked products following a change in the 
cross-linker molecular weight. All cross-linking experiments were checked following 
these guidelines, and experiments not satisfying each criterion were discarded. 
Automated peptide assignments (ASAP). For each LC-MS experiment on CNBr- 
digested cross-linked rhodopsin, mass spectra were calibrated by identifying a MS 
spectrum in the LC-MS run which contained relatively intense peaks of unmodified 
rhodopsin peptides known to be present in the control spectrum. (These control peaks 
were initially identified by standard comparison of their measured masses to expected 
CNBr product masses.) The exact monoisotopic masses of these peaks were then used to 
generate calibration constants that were applied to all spectra in the run, generally 
resulting in mass accuracies better than 10 ppm across the run (see Tables 1 and 2). 
Reduction of the MS spectra is automated by a macro developed in our laboratory and 
implemented in the Xmass software package (Bruker Daltonics), resulting in an output 
list of monoisotopic masses which could then be matched to a theoretical library of 
unmodified, labeled, andor cross-linked peptides generated by ASAP (Automated 
Spectrum Assignment Program) as described previously.(ld) For each monoisotopic 
mass in the experimental results, ASAP searched the library for masses within f 5-10 
ppm and reported all matching assignments. 
Identification of cross-links. Peaks assigned to cross-linked peptides by ASAP were 
manually checked to confirm reasonable peak shapes, isotopic distributions, and high 
signal to noise ratios. In order to verify the presence of putative cross-linked species, the 
LC-MS run and the identified peaks were then checked against the criteria outlined above 
(see Criteria for identification). In addition, for each cross-linked species identified (e.g. 
5046x3 18-348), the mass spectrum was also checked for the presence of the precursor 
peptides (e.g. un-modified 50-86 and 3 18-348) and the presence of ‘hanging’ cross- 
linkers on each precursor peptide. Since these species were generally found in greater 
abundance (data not shown), their presence and relative intensities were checked for 
consistency when assigning the putative cross-linked products. 
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A summary of all confirmed cross-linked peptides observed from the native state of 
dark-adapted rhodopsin in ROS is shown (Tables 1 and 2). Minor, but significant, 
differences were observed in the cross-linking pattern produced by each of the four 
cysteine-lysine cross-linkers, SIA, GMBS, EMCS, and LC-SMCC. Based on the 
assignment criteria described above, cross-links were identified between the cysteine and 
lysine residues present on the cytoplasmic face of rhodopsin (Figure 3) in peptides 50-86, 
310-317,318-348, and 87-143. Cross-linked peptide pairs, 50-86x310-317 and 50- 
86x3 18-348 were observed in all cysteine-lysine cross-linking experiments, however the 
cross-links in peptide 87- 143 (C 140xK14 1) and peptide 3 10-3 17 (C3 16xK3 1 1) were not 
detected with the shortest cross-linker, SIA (Table 1). Cross-linking results with the 
three homobifunctional NHS ester cross-linking reagents, DST, DSG, and DSS are also 
reported (Table 2). Cross-links between the lysine residues on the cytoplasmic face of 
rhodopsin were identified in peptides 50-86,3 10-3 17, and 3 18-348. An almost identical 
cross-linking pattern was observed with all three lysine-lysine cross-linkers, except in the 
case of K325xK339 which was not detected with the shortest cross-linker, DST, 
although the single ‘dangling’ hydrolyzed cross-link was observed (peptide 3 18-348 + 2 
palmitoyl groups + hydrolyzed DST, observed M+H+ = 373 1.9402 Da, A ppm = 2). No 
cross-links were observed involving Lys 296, the retinal attachment site, or Lys 16, 
located on the extracellular side of the membrane. 
the cross-linked species is due to the high mass accuracy and resolution of Fourier 
transform ion cyclotron resonance (FTICR) mass spectrometry, as well as the use of 
unmodified peptides for internal calibration. This degree of mass accuracy is sufficiently 
high enough to provide unambiguous assignment of each cross-linked species without the 
use of isotopically labeled reagents or MS/MS. In addition, the appearance of new 
peptide species in the spectra of cross-linked rhodopsin relative to control, and that these 
unique species are observed for cross-linkers of the same specificity but different linker 
length with the expected mass shifts, provides a degree of redundancy to further confirm 
the identity of the cross-linked products. For example, in Figure 4 spectra show a cross- 
linked peptide pair, 50-86 and 3 10-3 17, that is formed with four different C-K cross- 
linkers: SIA, GMBS, EMCS, and LC-SMCC. In each spectrum, the peak is novel 
relative to the control spectrum of rhodpsin CNBr digest products (not shown), and the 
relative mass shift between spectra corresponds to the difference in mass of the cross- 
linkers. In this way, using cross-linkers of different mass provides further confirmation 
of cross-link assignments. 
MS/MS. Three rhodopsin peptides resulting from CNBr digestion contain more than 
one lysine. To determine unambiguously which lysines were involved in cross-link 
assignments involving these peptides, we performed tandem MS experiments. Due to the 
high MW and low abundance of the cross-linked species, we were unable to perform 
data-dependent LC-MSMS experiments. Instead, cross-linked products were purified by 
semi-preparative HPLC and analyzed by direct infusion. Fractions were collected and 
tested by direct infusion Q-Tof-MS to identify those containing cross-linked species. 
These fractions were then analyzed by direct infusion M S N S  as described below. 
Several of the cross-linked peptides posed particular problems for analysis by tandem 
MS. The peptide 50 - 86 contains two adjacent lysines in the center of the peptide that 
could not be sequenced by FT-MSMS using collision-induced dissociation (CID) or 
The low experimental error (A ppm) between the theoretical and observed masses of 
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infrared multi-photon dissociation (IRMPD) or by Q-Tof-MUMS using CID. However, 
it was found that FT-MS/MS using electron capture dissociation (ECD) resulted in 
fragmentation through the center of the peptide. Thus, several cross-link assignments 
containing peptide 50 - 86, notably 50 - 86 x 3 10 - 3 17 (K66 or K67 cross-linked to 
C3 1 1) and 50 - 86 x 3 18 - 348 (residues K66 or K67 cross-linked to K325 or K339) 
were disambiguated using this technique. The FT-MS/MS studies involving CID, 
IRMPD, and ECD techniques is being prepared in a separate report and are only 
summarized here (see Tables). These results show that K67 and not K66 participate in 
cross-linking with C3 16, K325, and K339. One assignment, 50 - 86 x 310 - 317 
(K66/67 x K3 1 1) occurred in too low abundance to perform MS/MS on. However, as 
discussed below, we believe the lysine participating in this cross-link can be inferred 
based on other data. 
The peptide 3 18 - 348, which contains two well-separated lysines in position 325 and 
339, was fragmented effectively by Q-Tof-MS/MS using CID. The results of two such 
experiments involving the peptide pair 3 18 - 348 and 3 10 - 3 17 cross-linked with either 
C - K or K - K cross-linkers are shown in Figures 4 and 5 ,  respectively. An interesting 
cross-linking pattern is revealed by this data: C3 1 1 cross-links selectively to K325 while 
K3 16, on the same CNBr peptide as C3 1 1, is linked preferentially to K339. Since CID 
can fragment at the amide bond between the epsilon amino group of lysine and the 
carbonyl of the linker arm, it isn’t possible to entirely rule out a cross-link based on its 
absence in a CID MSMS spectrum. However, extensive y- and b- ion series directly 
confirming the cross-links described above were observed in the MSMS spectra (see 
Figures 4 and 5), suggesting that these are the major products. In the case of cross-link 
C3 16 x K325, nearly identical spectra were observed following CID fragmentation of 
peptides cross-linked with three different reagents, SIA, GMBS, and LC-SMCC, which 
have a large range of linker arm lengths. All three spectra show indirect evidence that a 
very small portion of the cross-linking could occur between C3 16 and K339, in the form 
of an b ion fragment containing the unmodified sequence 3 18 to 326. However, this is a 
minor peak and could also be formed by a double fragmentation at both the amide bond 
in the cross-link and just before P327, which in control MS/MS experiments with peptide 
3 18 - 348 is one of the major points of fragmentation. 
A summary of cross-linked peptides and residue assignments is given for C - K and K 
- K cross-links in Tables I and 11, respectively. 
Lysine reactivity. Several factors likely contribute to the pattern of cross-linking 
observed. These include the distance between the residues, the overall mobility of the 
reactive atoms, the reactivity and accessibility of the residues, the stoichiometry of the 
reaction, and the relative abundance of the reaction products. To address the question of 
relative reactivity of residues involved in cross-linking, cysteine and lysine labeling 
experiments were performed. It was shown previously that only two cysteine residues, 
C140 and C3 16 are reactive under mild conditions (6, 48, 49) and results under our 
conditions using N-ethyl-maleimide were similar (data now shown). By contrast, 4- 
vinylpyridine at 50mM reacts with all reduced cysteines, as shown recently by (45). 
We used a two-step labeling protocol to designed to allow quantitative analysis of 
relative lysine reactivity by tandem MS. Lysines were first labeled with NHS- 
proprionate using stoichometry and buffer conditions similar to those used for lysine 
cross-linking. Unlabeled lysines were then alkylated with NHS-acetate at > 5000-fold 
19 
molar excess to promote complete labeling. If the assumption is made the difference 
between acetyl and proprionyl groups will not change the ionization and fragmentation 
of a peptide, we can then directly compare the relative amounts of proprionated (ie. 
reactive) and acetylated (ie. unreacted) lysines in peptides containing one or more lysines. 
An example is shown in Figure 7. The MSMS spectrum of CNBr peptide 3 18 - 348 
containing one acetyl and one proprionyl group contains a b-ion series through the first 
lysine, K325. This lysine can be seen in both proprionated and acetylated form in 
approximately equal proportion. 
peptide 50 - 86 proved resistant to CID fragmentation though the lysines, so we 
performed a trypsin / CNBr double digest and MSMS on the fragment 50 - 69, which is 
cleaved at an N-terminal Met and a C-terminal Arg, containing one propionyll and one 
acetyl group. Based on the y3 ion, which contains containing only K67, the ratio of 
proprionyl- to acetyl-lysine was about 80:20, indicating that K67 is the more reactive of 
the two lysines on this peptide (data not shown). This is consistent with MSMS data of 
cross-linked peptides, where only cross-links involving K67 were detected. 
We also used this method to compare the reactivities of K66 and K67. The CNBr 
Computational Analysis 
Cross-linker distance constraints. In order to estimate the distances between reactive 
atoms joined by cross-links, the length of the cross-linker between the side-chain N or S 
atoms attached to the linker molecule was considered. Although recent studies have 
reported the average span and flexibility of commonly used cross-linkers,(50) the cross- 
linking experiment takes place on a minute-to-hour time scale. Extended conformations 
of the linker arm are accessible in these time-scales and therefore the maximum linker 
length should provide a useful upper bound on experimental cross-linked distances. 
Tables 1 and 2 report these distances, which were determined using a 3-D structure of the 
cross-linker constructed in Chem3D(30) and optimized using MM3(31-33) (refer to 
Methods section). Calculated maximum lengths are in good agreement with the upper 
range of N-N distances reported by Houk and co-workers(50) for the Lys-Lys cross- 
linkers, DST, DSG, and DSS (the Cys-Lys cross-linkers were not considered in their 
study). 
used to set a lower bound on the distance of greatest separation (DGS) between two 
reactive atoms in a protein. However, for the reagents we have employed, these 
minimum lengths are only in a few cases greater than the maximal lengths of the shorter 
cross-linkers for which cross-links were found (only in the case where LC-SMCC cross- 
links were found and SIA cross-links were also, see Tables 1 and 3). Simply given the 
conformational flexibility of side chains (especially lysine), the DGS will generally be 
many Angstroms greater than the DCA ( e g ,  at least 12-13 8, greater for any cross-link 
involving a lysine residue), for which we have been able to experimentally define 
absolute bounds to within < 6 8, in all cases, given that the minimum possible DCA is 
defined by the Van der Waals radii of the reacting atoms. Because no reagents are 
currently available that can effectively probe the appropriate distance range to set a usefbl 
bound on the DGS, we chose to computationally evaluate each cross-linker only in terms 
of the ability of its maximum length to bound the DCA. Thus, each distance constraint 
In principal, the minimum length conformation of the cross-linking reagent can be also 
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used in our molecular modeling corresponds to the predicted maximum length of the 
shortest cross-linker for which a cross-link was detected. 
Comparison of experimental and structure predicted distances. Comparison of 
cross-linked distances to those calculated from the known structure of bovine rhodopsin 
was achieved using a hierarchy of computational approaches, as described in the 
methods. A baseline comparison was first made between the cross-linked distances on 
the cytoplasmic face of rhodopsin and the side-chain distances (S-N or N-N distances) 
measured from the energy minimized X-ray structure.(l7) However, since the crystal 
structure represents a single static picture of the protein structure, conformational search 
procedures were also used to investigate other energetically realistic side-chain and/or 
backbone orientations that could give rise to the experimentally observed cross-links not 
validated by direct measurement of the crystal structure. For each cross-linked peptide, 
we compared the candidate inter-atomic distances required to account for the observed 
cross-linked peptides to ensembles compiled from a) a 40 ns molecular dynamics 
simulation of dark-adapted bovine rhodopsin in an explicit lipid bilayer,(21) referred to 
as method MD, and b) constrained energy minimization of structures from an ensemble 
generated by Monte Carlo conformational searches with flexible side-chains and fixed 
backbone, referred to as method MC-SC-CM. Duing constrained energy minimization 
of structures from the Monte Carlo ensemble, the cross-linked side-chains are biased 
toward orientations that bring them within the cross-linker length by inclusion of a 
distance constraint potential in the CHARMM22 force field. Table 3 summarizes the 
results of these structural comparisons. 
Discussion 
Recent reports on the use of covalent cross-links to constrain structural models of 
proteins, stimulated in part by advances in high-resolution mass spectrometry, raise 
important issues regarding the general applicability of the MS3-D method and the 
interpretation of cross-links as valid inter-atomic and inter-residue distance constraints. 
In this work, we describe general methods that help extend the applicability of this 
approach to membrane proteins and protein complexes. We also present an initial set of 
computational methods for relating the observed cross-linked peptides to the structure 
and dynamics of our model membrane protein, bovine rhodopsin. 
Protein cross-linking and mass spectrometric mapping of cross-linked peptides. 
The mass spectrometric mapping and analysis of chemical cross-links is a challenge, 
especially for membrane proteins in their native environment. For rhodopsin in the ROS 
membrane, it is not possible to control the local concentration of protein, and covalent 
homodimers and heterodimers are inevitably formed during the cross-linking reaction. 
As a result, a micro-preparative method for high-resolution protein separation is 
necessary in order to isolate intra-molecularly cross-linked monomers. We found 
preparative tube-gel eletrophoresis followed by fraction collection provided excellent 
molecular weight resolution (compared to size-exclusion chromatography(l6)) and 
sample recovery (compared to slab PAGE and electroelution). Complete reduction and 
alkylation of all cysteines was accomplished using TCEP and 4-vinlypyridine, and 
ch1oroform:methanol:water precipitation worked well for the removal of detergents (and 
other reagents such as the 4-VP). Tryptic digests in the absence or presence of detergent 
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gave poor cleavage efficiency and low sequence coverage compared with CNBr digestion 
in 70% TFA, which resulted in nearly complete cleavage and complete sequence 
coverage along with excellent reproducibility (see also (40, 41)). We found in-gel digests 
were of limited use in our study, since larger hydrophobic peptides poorly from the gel 
and in general yields were low (data not shown). 
The overall framework we advocate for MS3-D experiments is to use multiple cross- 
linking reagents with different reactivities and to scan the length of the cross-linker. 
Previous reports with this method have focused primarily on the formation of lysine- 
lysine cross-links.(16, 19, 28, 51) We have demonstrated that, in addition to lysine-lysine 
cross-links, multiple lysine-cysteine cross-linked peptides can be identified from a 
protein such as rhodopsin with native exposed sulfhydryls (and presumably for proteins 
with cysteines introduced through site-specific mutation). As outlined in the Results 
section above, we have established criteria and methods for data analysis that allow 
identification of cross-linked peptides with a high degree of reliability. These methods 
rely not only on the high mass resolution of FTMS, but the use of a series of cross-linking 
reagents with nested backbone lengths, which allow the experiment, under favorable 
circumstances, to define inter-atomic distances, rather than just upper constraints on 
inter-residue distances.(19, 20) We believe that this approach is superior to using mixed 
isotopically-labeled reagents and pattern recognition for data analysis and cross-linked 
peptide identification(52, 53) for at least three reasons: 1) splitting a low-abundance peak 
into a labeled and un-labeled peak reduces its signal, making it hard to definitively 
identify the monoisotopic 12C or single 13C peak, 2) isotopically-labeled reagents are 
unnecessary: our results show that with sufficient mass accuracy, the peaks of cross- 
linked peptides can be identified without isotopically-labeled reagents, and 3) if desired, 
commercially available reagents differing by one of a few carbons in linker length can be 
mixed in two or more experiments, enabling pattern recognition for identification of 
modified peptides without the need for expensive labeled reagents, and giving additional 
information on distance constraints. 
suppression, peak overlap, and the low relative abundance of cross-linked products can 
all lead to low intensity and poor mass spectrometric detection. As a result, it is difficult 
to draw conclusions about cross-linked peptides that are not found in experiments with 
linkers of any length but might be expected to form based on the crystal structure. For 
example, no cross-linked peptides were identified in this study involving either the N- 
terminal face of rhodopsin or the cytoplasmic loop I11 (C-111) between helix V and VI. In 
addition, only one cross-link, C 140x1~14 1, was found in the cytoplasmic loop I1 (C-11). 
Dangling lysine modifications were found for the N-terminal peptide 2-39 and the C-I11 
loop peptide 208-253, suggesting that a lack of reactivity cannot account the absence of 
inter-peptide crosslinks. Labeling studies with N-hydroxysuccinimidyl acetate (NHS- 
Ac), which specifically acetylates primary amines, have shown that K23 1, K245, and 
K248 (located in or near the third cytoplasmic loop) are all reactive to some degree, as 
indicated by LC-MS detection of singly, doubly, and triply acetylated products of peptide 
208-253 (see Supplementary section). Distance measurements taken from the X-ray 
structure and from the MD simulation also do not seem to offer explanation for the 
complete absence of cross-links. For example, such measurements suggest that it should 
be possible to form the K23 lxK245 cross-link using the cross-linker DSS, and the 
As always with MS-based analysis of complex samples, issues such as ionization 
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K23 1xK248 and the K245xK248 cross-links using the cross-linkers DSS, DSG and DST. 
Further investigation will be required to determine whether cross-links involving this 
peptide are present and simply not detected by our LC-MS methods, or if intra-molecular 
cross-linking is prevented, for example due to rhodopsin dimer interactions.(54) With 
regard to the N-terminal face, with our reagent set, only one cross-link would even be 
possible on the N-terminal face (K16xC 184), and if it were present, the multiple 
glycoforms of the N-terminal peptide make its identification problematic. 
Computational analysis. Our computational analysis was directed at answering three 
1) Are the observed cross-linked peptides compatible with the crystal structure 
2) Are the observed cross-links compatible with realistic side-chain and backbone 
3) Does the use of cross-linkers with nested lengths allow the determination of inter- 
The first question has bearing on the issue of whether the cross-linking reactions distort 
questions: 
backbone if side-chain rearrangements are allowed? 
dynamics? 
atomic distances, rather than simply upper bounds on distances? 
or denature the protein. We deemed a cross-linked peptide compatible with the X-ray 
structure backbone if at least one of the possible inter-atomic cross-links that could 
account for the observed peptide was within the distance defined by the maximal length 
of the cross-linking reagent, as observed by either a) the energy minimized X-ray crystal 
structure orb) Monte Carlo sampling of side-chain conformations followed by 
constrained minimization and relaxation of the relevant inter-atomic distances (method 
MC-SC-CM). We found that at least one such cross-linkable atomic pair distance could 
in fact be found to account for each observed cross-linked peptide (see Table 3). Few 
cross-links, however, were directly consistent with the energy minimized X-ray structure: 
the unambiguous cross-links K3 1 1xC3 16 and K141xC140, and the potential cross-link 
K67xK339. Further experimental work to resolve the identities of the actual atom pairs 
(rather than just the peptides) involved in each of the cross-links is needed to determine if 
the atomic-pairs that achieved the minimum DCA upon MC side-chain sampling are in 
fact the ones involved in the formation of the cross-linked peptide. Based on the result 
presented here, though, none of the observed cross-linked peptides require major 
backbone rearrangements from the X-ray structure, and therefore there is no indication 
that the cross-linking reactions somehow force the protein into non-native conformations. 
It should be noted that these experiments proceed very differently than those involving 
introduction of site-specific cysteine mutations and assaying for formation of disulfide 
bonds in order to provide distance constraints. In these experiments, the redox potential 
of the reaction mixture may provide a source of free energy that drives the protein into 
unfavorable conformations, and there are possible effects involving disulfide bond 
formation or failure of bond formation during or after folding. In MS3-D, the cross- 
linking reagent first attaches one end to a reactive residue on the native protein, and then 
the other end of the reagent samples the surrounding environment, where it may or may 
not come across an appropriately reactive atom on another residue. The greatest potential 
source of cross-links that do not reflect the native structure appears to be from denatured 
protein that is either present in the preparation, or potentially induced by excessive 
23 
concentrations of the alkylating cross-linking reagent. These effects were controlled in 
our experiments by spectroscopic measurements on the ROS preparations that confirmed 
that the retinal was attached in its native environment, and by using limiting 
concentrations of the cross-linking reagent (see Methods). 
One possible objection to using distances resulting from the constrained minimization 
of structures from the Monte Carlo sampled side-chain conformational ensemble is that 
we did not use explicit solvent or lipid (due to the high computational cost) and that the 
sampling is done at elevated temperature. As a result, it is not possible, even after 
minimization, to properly determine the energetic perturbation of the sampled structures 
relative to the crystal structure. This consideration prompts the second question above. 
Molecular dynamics simulation methods allow the sampling of thermal fluctuations about 
the crystal structure, including backbone motion, and we can use a MD simulation with 
explicit lipid and solvent to address the second question raised above. One limitation to 
this approach, however, is due to the fact that cross-linking experiments sample 
conformations on a time-scale of minutes or even hours, and the MD simulation of a 
membrane protein with explicit solvent and lipid takes one day per nanosecond even on a 
massively parallel computer.(21) The sets of corresponding K-K and C-K distances 
extracted from the rhodopsin MD trajectory at 20 ps time-intervals account for all of the 
unambiguous cross-links on the internally cross-linked peptides 50-86, 87-143,3 10-3 17, 
3 18-348 (for all cross-linker lengths observed), but do not account for any of the cross- 
links formed between peptides on different loops. This result suggests that 40 ns is not 
sufficient to sample all of the relevant conformations. This is clearly seen in the case of 
peptide 5046x3 18-348, where, partly due to fairly small initial backbone rearrangements 
that occur during equilibration of the MD ensemble, the DCA of K67xK339 reaches only 
9.2 8, even though the minimized X-ray structure has a distance of 6.2 A (Table 3). This 
result is perhaps indicative of why MD succeeds for internal cross-links, requiring only 
side-chain rearrangements, but fails for longer cross-links: it is much more difficult to 
sample large-scale relative backbone motions than to sample local motions. Conversely, 
this result suggests that cross-linking can be an experimental tool to probe backbone 
rearrangements that can occur on microsecond and longer time scales. 
Regarding the third question, of the four cross-linked peptides observed that admit 
unambiguous assignment of the identity of the cross-linked atoms (C 140xK141, 
C3 16xK3 1 1, K325xK339 and K66xK67), the first three display the following 
phenomenon: cross-links are found with all but the shortest of the reagents in the series. 
We cannot completely rule out a role for differences in reactivity of the shortest reagents 
(SIA has an iodomethyl rather than a maledimide sulfhydryl-reactive moiety and DST 
has bulky hydroxyl side chains), but based on the fact that these reagents readily form 
other cross-links, this seems unlikely. (Experiments are now underway to resolve this 
issue using strictly homologous cross-linking reagents differing only by the linker arm 
length.) Using the data at hand and employing the maximum length of the shortest cross- 
linker as a minimum bound on the DCA, the implied DCA for C140xK141 and 
C3 16xK3 11 is 4.0 - 9.7 A, while for K325xK339 the DCA between the two reactive 
amines is 6.3 - 7.4 8,. For C140xK141 and for C316xK311 the DCA found by distance 
constrained energy minimization of structures from the side chain Monte Carlo ensemble 
was 3.3 and 3.2 8,, respectively (essentially corresponding to van der Waals contact), so 
that in any case the lower bound of 4.0 8, on the DCA derived from the maximally 
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extended conformation of SIA is accurate to within an Angstrom. For K325xK339, 
constrained side-chain MC finds a minimum distance of 3.9 A, indicating a somewhat 
larger error in the experimental lower bound on the DCA. From the MD trajectory, 
however, we find that close distances of approach between K325 and K339 are 
accompanied by a large reduction in solvent accessibility of the reactive groups (data not 
shown), so that steric effects may be related to the inability of this cross-link to form. 
This observation suggests further simulation experiments are needed, since the relevant 
dynamics to be examined in cross-link formation are that of a protein with one end of the 
cross-linker already attached to an amino acid side-chain. In the native protein, compact 
side chain conformations may be achievable which are sterically or entropically 
unfavorable when one of the side chains has a dangling cross-linker attached. A 
systematic program of experiment and simulation across many proteins is needed to 
understand the impact of these effects on bounding the DCA, but could result in a 
calibrated molecular “tape measure”(20) for general use in protein structural studies. 
Exact identification of the cross-linked residues in various observed cross-linked 
peptides will result in a more detailed structural analysis; however the results presented 
here are consistent with the known structure and dynamics of rhodopsin. Earlier studies 
have demonstrated the flexibility of rhodopsin’s cytoplasmic loops and C-terminus.(l7) 
Khorana and co-workers{Cai, 1999 #53; Cai, 1997 #5 1) observed the formation of 
cysteine-cysteine disulfide bridges between residues on the cytoplasmic face of rhodopsin 
that are greater than 12 8, apart (C,-C,) in the X-ray crystal structure (see review by 
Meng et a1.(55)). Strictly speaking, our modeling results did not require exceptional 
backbone flexibility to account for the experimental results, although the observation that 
cross-links form between all pairs of 50-86, 3 10-3 17, and 3 18-348 at DCAs that are 
generally several angstroms shorter than those in the X-ray structure or the MD trajectory, 
are consistent with the hypothesis that the C-terminal peptides have substantial backbone 
mobility. Although the use of a broader range of cross-linking reagents of varying 
length, rigidity, and reactivity will aid the structural modeling of cross-linked rhodopsin 
(e.g., by allowing us to derive upper- and lower-bounds on the distances of closest 
approach for cross-linked atoms), the results presented here demonstrate the potential of 
MS3-D in the identification of three-dimensional distance constraints for integral 
membrane proteins, and as a probe for local conformational mobility. 
Chemical cross-linking based structure prediction. It is not likely that de novo 
modeling based purely on cross-linked distance constraints will be feasible in the near 
future, however it is already demonstrated that modeling approaches that incorporate 
cross-link-based distance constraints (either alone or in combination with other 
experimental distances) can provide a useful tool in protein structure prediction. The 
implementation of structural restraints into threading and fold recognition studies has 
recently been reported by several groups.(l6, 56) Lengauer and co-workers 
demonstrated a 30% improvement in correct fold recognition rates when using cross- 
linking and NMR distance constraints with the 123D threading algorithm.(57, 58) Koster 
and co-workers have used chemical cross-linking and mass spectrometry to identify 
likely models for sequences with less than 30% homology to known structures.(59) In 
the case of membrane proteins, our group has recently reported a computational 
technique for correctly identifying helix-membrane protein folds matching a pre-defined 
set of distance constraints from NMR NOE, chemical cross-linking, dipolar EPR, and 
25 
FRET experiments.(Z8) Based on these modeling results, methods that would enable the 
rapid identification of experimental distance constraints by chemical cross-linking and 
mass spectrometry would contribute significantly to advances in membrane protein 
structure determination. We believe that we have overcome the principal difficulties in 
sample preparation and processing of membrane proteins required to effectively 
implement such methods. By using rigorous criteria in the identification of cross-linked 
species, and by validating cross-linked distances based on the known X-ray structure of 
rhodopsin, we have demonstrated the potential use of chemical cross-linking, mass 
spectrometry, and modeling (MS3-D) in the three-dimensional structural analysis of 
membrane proteins. Examination of the cross-linking results using computational models 
indicates that both structural and dynamical information may be recoverable from such 
experiments. 
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Tables 
peptides SIA GMBS EMCS residues 
4.0 A' 9.7 A 11.1 w 
Table 1. Observed M + Hf (Da) and experimental error (ppm) of cysteine-lysine 
cross-linked rhodopsin peptides. Protonated masses correspond to the monisotopic 
peak unless indicated. 
LC-SMCC 
15.0 A 
5272.9097 5397.9458 
3. 7ppm 7.2 ppm 
4632.4380 4756.4448 C316xK325 310-317, 318-3482 1.1 pprn 7.0 ppm 
C3 16xK67 310-317,50-86 
5425.9624 5565.0869 
0.8 pprn 4.0 ppm 
4784.4668 4923.5869 
3.0 pprn 1.2 pprn 
not I 6414.2285 I 6442.227 I 6581.4228 1 C140xK141 1 87-1433 I observed 4.3ppm4 9.4 ppm4 5.4 ppm4 1 not I 1157.5200 I 1185.5441 1 1324.6490 
observed 3.4 ppm 2.9 ppm 1.3 ppm I C316xK311 I 310-317 
Maximum cross-linker length (see text for details). 
Contains 2 palmitoylated cys. 
Contains 1 pyridylethylated cys. 
Monoisotopic peak not observed, assignment based on second isotope peak. 
2 
4 
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Table 2. Observed M + Hf (Da) and experimental error (ppm) of lysine-lysine cross- 
linked rhodopsin CNBr digest products. Protonated masses correspond to the 
monisotopic peak unless indicated. 
I
Cross-linked 
residues 
K67xK325 and 
K67xK3 3 9 
K3 1 1xK66/67 
K311xK339 
K66xK67 
K3 2 5xK3 3 9 
Observed mass of Lys-Lys cross-linked peptides 
6.3 A' 7.4 A 11.3 A 
Cross-linked 
peptides DST DSG DSS 
7937.4268 1 7979.4067 I I 7955-3447 1.6 ppm  I 5.5 ppm4 3.0 ppm4 50-86,3 1 8-3482 
5434.9717 1 5475.9912 I I 5451-9126 5.8 ppm I 0.3 ppm4 4.7 ppm 50-86, 310-3173 
4835.54 1 
1 .O ppm4 0.9 ppm4 3 10-3 1 73, 3 1 8-3482 
50-86 4338.4404 I 4379.4756 1 I 4355.3784 9.6 pprn I 2.1 ppm4 4.0 ppm 
3696.9828 I 3737.9888 1 
4.6 ppm4 5.6 ppm not observed 3 1 8-3482 
I Maximum cross-linker length (see text for details). 
Contains 1 pyridylethylated cys. 
Monoisotopic peak not observed, assignment based on second isotope peak. 
* Contains 2 palmitoylated cys. 
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Table 3. Comparisons of minimum cross-linker length and theoretical minimum 
approach distances for theoretical (italics) and observed (bold) cross-linked atoms. 
Cross- 
linked 
residues 
Cross-linked 
peptide(s) 
Distance of Closest Approach (A)  X-ray MC-SC-CM Max. reach of shortest observed cross- link' (hi) 
87-143 
3 10-3 17 
7.4 K325xK33 9 3 18-348 16.1 3.9 4.9 
208-257 
K67xC316 
K339xC316 
50-86,310-317 
3 18-348, 3 10-3 17 
4.0 9.2 3.1 9.9 
11.7 3.4 9.0 
5046,310-3 17 
K67xK3 1 1 
K311xK32.5 
3 18-348,3 10-3 17 
6.3 14.5 5.8 18.8 
19.1 6.4 13.5 
50-86.3 18-348 
K66xK325 
K66xK339 
18.3 7.6 17.3 
9.9 2.9 7. I 
K141xC140 I 9.7 I 9.5 I 3.3 I 7.3 
K67xK339 
K311xC316 I 9.7 I 9.3 I 3.2 I 8.8 
6.3 (7.4) 6.2 3.0 9.2 
K66xK67 I 6.3 I 13.4 I 3.1 I 5.7 
K231xK245 I I 1 1 
K245xK248 I I i i 
K248xK231 I I 1 1 
K66xC3161 I ~ 13.1 1 3.2 I 11.0 
K325xC3 14 4.0 1 15.2 -1 7.5 I 9.6 
K66xK311- 6 3  I -~ 22.3 I 11.1 I 23.3 
K311xK33 I 6.3 (7.4) I 16.9 I 5.2 1 14.9 9 
K67xK325-16.3( 1 1.1) 1 18.5 -1 6.4 10.7 
Length between reactive atoms of the most extended structure of the shortest cross-linker for which a 
cross-link was detected. If the cross-link was ambiguous, the shortest cross-link for which ms/ms was 
performed to identify the exact residues involved is shown in parenthesis. 
to energy (CHARMM22) minimized X-ray structure (1F88) (K339 side-chain atoms beyond the Cp atom 
were modeled using the internal coordinates table in the CHARMM22 lysine topology); MC-SC-CM, 
refers to constrained energy minimization of structures from the Monte Carlo conformational search with 
fixed backbone; MD refers to the 40 ns MD simulation. 
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The distance of closest approach for pairs of cross-linked atoms was determined as follows: X-ray, refers 2 
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Figures 
Figure 1. Cross-linking and purification of monomeric dark-adapted rhodopsin as 
visualized by Coomassie-stained 4-20% Tris-Glycine SDS-PAGE. (a) Lane 1, Mark 
lZTM Protein ladder (Invitrogen); lane 2, reduced and alkylated rhodopsin in ROS 
(control); lanes 3-7, reduced and alkylated rhodopsin in ROS following cross- 
linking; @) Lanes 1 & 8, Mark l 2 T M  Protein ladder (Invitrogen); lanes 2-7, Cross- 
linked monomeric rhodopsin fractions after purification by tube gel electrophoresis. 
- 
1 2 3 4 5 6 7  1 2 3 4 5 6 7  
I 
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Figure 2. Total ion chromatograms (TICS) of the reverse phase HPLC separation on 
a PRLP-S column and ESI-FTMS of CNBr-digested (a) rhodopsin and (b) EMCS 
cross-linked rhodopsin. Selected ion chromatograms (SICs) from the EMCS cross- 
linked spectrum of the most abundant isotope peak for (c) peptide 50-86 cross- 
linked to peptide 310-317 (expanded vertically 4-fold) and (d) the unmodified 
CNBr peptide 5 0 4 6 .  The SICs are shown to scale overlaid on the TIC. All post- 
translational modifications were observed; free cysteines were pyridylethylated. 
164-183 and A 
(II c --A- 
I 1  
~ 4x 
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Figure 3. Mass spectra of rhodopsin CNBr digest peptides 50 - 86 and 310 - 317 
cross-linked with Cys-Lys cross-linkers of different linker arm length. A single 
spectrum from an LC-MS experiment is shown for each cross-linker and the 
monoisotopic peak is indicated for (a) SIA, m/z 1055.3881+5, signalhoise (S/N) = 
241.4, (b) GMBS, m/z 1080.38319+5, S/N = 717.7, (c) EMCS, m/z 1085.9978f5, S/N = 
462.7, (d) LC-SMCC, m/z 1113.8155+5, S/N = 344.6. S/N is based on most abundant 
isotope peak. See Table 1 for M + H+ (Da) and experimental error (A ppm). 
* 
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Figure 4. ESI-Q-Tof-MS2 of rhodopsin CNBr digest fragments 310 - 317 and 318 - 
348 cross-linked with the hetero-bifunctional Cys/Lys-specific reagent LC-SMCC. 
A cross-link was selectively formed between Cys316 of peptide 310 - 317 and Lys325 
of peptide 318 - 348. The spectrum is labeled with major b-, y-, and internal ion 
series; a cross-link between fragments is indicated by an ‘x’. Cys322 and Cys323 
are palmitoylated and Met317 is modified to homoserine lactone by CNBr cleavage. 
The largest peaks have been truncated. 
200 300 400 500 600 700 800 900 
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Figure 5. ESI-Q-Tof-MS2 of rhodopsin CNBr digest fragments 310 - 317 and 318 - 348 
cross-linked by the homo-bifunctional Lys/Lys-specific reagent DSG. The cross-link 
was selectively formed between between Lys311 of peptide 310 - 317 and Lys339 of 
peptide 318 - 348. The spectrum is labeled with major b-, y-, and internal ion series; a 
cross-link between fragments is indicated by an 'x'. Cys322 and Cys323 are 
palmitoylated, Cys316 is pyridylethylated, and Met317 is modified to homoserine 
lactone by CNBr cleavage. The largest peaks have been truncated. 
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Figure 6. Cytoplasmic face of rhodopsin displaying chemically reactive Cys and Lys 
side chains. Solid lines indicate un-ambiguous cross-links, including C316xK67, 
C316xK325, C316xK311, K67xK339, K67xK325, K66x67, and K325xK339. Dashed 
lines represent ambiguous cross-link assignments, including C316xK66/67 and a 
cross-link involving K231/K245/K248. Helical domains I - VI11 and loops CI - CIII 
are labeled, arrows indicate the C-terminal direction of the loops. 
Figure 7. The simulated distance of closest approach (DCA, see Methods) between 
for cross-linked atom pairs is plotted against the minimum cross-linker arm length 
observed to form a cross-link between each pair. Horizontal error bars correspond 
to the vectorial sum of C alpha RMSDs for the cross-linked residues taken from the 
crystal structure B factors. The DCA is less than the cross-linker arm length, except 
for K325 cross-linked to C316, suggesting that additional movement beyond that 
considered in the DCA simulation is required for this cross-link to form. 
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Supplemental Figure 2. Cysteine-Lysine Cross-linkers 
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Unambiguous Assignment of Intra-Molecular Chemical Cross-links in Modified 
Mammalian Membrane Proteins by FT-MS/MS 
Abstract 
Fouria-transfonn tandem mass spectrometry (FT-MSMS) can be used to unambiguously assign 
intra-molecular chemical cross-links to specific amino acid residue(s) when two or more possible 
even when cross-linking sites are adjacent in the cross-linked protein. Bovine Rhodopsin (Rho) in 
its dark-adapted state was intra-molecularly cross-linked with lysine-cysteine (K-C) or lysine-lysine 
(K-K) cross-linkers to obtain inter-atomic distance information. Large, multiply-charged, cross- 
linked peptide ions containing adjacent lysines, correspondmg to Rho5o-s (& or &7) cross-linked 
to Rh0310-317 (C316) or Rha18-m 6 3 2 5  or K339), were fragmented by collision-induced dissociation 
(CID), infrared multi-photon dissociation (IRMPD), and electron capture dissociation (ECD). 
Complementary sequence-specific information was obtained by combining cross-link assignments; 
however, only ECD revealed full palmitoylation of adjacent cysteines (C3n and C323) and aoss- 
linking Of &7 (and not &) to c316, K325, and K339. ECD spectra contained crucial c- and z-ions 
resulting fiom cleavage of the bond between & and &7. To our knowledge this is the first 
demonstration that ECD can be used to characterize S-linked fatty acid post translational 
modifications. The comprehensive hgmentation of large peptides by CID, IRMPD, and 
particularly ECD, in conjunction with the high resolution and mass accuracy of FT-MSMS, is 
shown to be a valuable means of characterizing mammalian membrane proteins with both 
chemical- and post-translational modifications. 
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Introduction 
Cross-linked peptides and proteins may be formed as part of natural or 
pathological post-translational modifications (PTMs) or during application of methods 
where covalent cross-linking reagents are used to define inter- or intra-molecular distance 
constraints. Inter-molecular cross-linking studies have focused on defining protein 
complex topology and protein-protein interactions, while intra-molecular cross-linking is 
primarily used for modeling the tertiary structure of proteins. Both types of experiments 
depend on deep extensive coverage of the cross-linked peptides and proteins which must 
be obtained despite the relatively low concentration of cross-linked species, missed 
cleavages, and various modifications. 
A bottom-up approach, referred to as MS3D1, was introduced in 1999 that 
combines the use of intra-molecular chemical cross-linking, proteolysis, and mass 
spectrometry to identify inter-residue cross-links in peptides, and then uses these cross- 
links to constrain three-dimensional structural models of proteins. Subsequent bottom-up 
MS3D studies2-' and more recent top-down studies of intact cross-linked proteins6, 
indicate that these approaches have promise for defining a significant number of inter- 
atomic distance constraints (see reviews" 9). However, it is particularly difficult to 
unambiguously assign intra-molecular chemical cross-links to specific amino acid 
residue(s) when two or more possible cross-linking sites are adjacent in the sequence of 
the cross-linked protein. 
Tandem mass spectrometry (MSMS) has been used throughout these studies to 
provide sequence-specific identification of cross-linked peptides and to improve 
confidence in cross-link assignments. However, in the bottom-up approach to MS3D, 
cross-linked peptide ions tend to be relatively large and of high mass-to-charge (m/z), 
making extensive fragmentation by MSMS problematic. Large peptides are often formed 
from cross-linked proteins during proteolysis due to missed cleavages and the fact that 
cross-links can join what would normally be two individual proteolytic peptides. Low 
charge states are often formed during electrospray ionization due to cross-linking of basic 
amino acid residues because the most commonly employed cross-linking reagents react 
with primary amino groups at lysine and the amino terminus. Moreover, the number of 
peptides with the same nominal mass but different amino acid sequence increases 
exponentially with the number of amino acid residues in the peptide. Thus, the high 
resolution and mass accuracy of Fourier-transform mass spectrometry (FT-MS)" and the 
ability to comprehensively fragment large peptides by FT-MSMS" are critical for 
unambiguous assignment of intra-molecular cross-links6' 12. 
The bottom-up MS3D method consists of several steps including: 1) cross-linking 
the protein in the native state, 2) purification and proteolysis of cross-linked monomers, 
3) analysis of peptides using liquid chromatography (LC) and mass spectrometry (MS), 
4) determination of cross-linked peptides by exact mass and cleavage specificity, 5 )  
assignment of cross-links to specific amino acid residue(s) by MSMS, 6) verification of 
cross-link assignments, and 7) calculation of inter-atomic distance constraints. Post- 
source decay (PSD)'? and collision-induced dissociation (CID)2' s were successfully 
applied in previous studies to provide b- and y-type ions; however, these and other 
vibrational excitation techniques (e.g., infrared multi-photon diss~ciation-IRMPD'~) 
often fail to discriminate the specific amino acids involved in a cross-link. Recently, 
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electron capture dissociation (ECD)I4-l6, a non-ergodic process, has proven to provide 
extensive backbone fragmentation for ions with labile PTMsl7> 18. Labile bonds to the 
modifying groups are usually the first to break during MS/MS with CID or IRMPD, 
making it difficult to localize these modifications, whereas ECD fragments the backbone 
without dissociation of these labile bonds. Therefore, we evaluated FT-MS/MS with CID, 
IRMPD, and ECD to determine how well they unambiguously assign intra-molecular 
chemical cross-links to specific amino acid residue(s) when two or more possible cross- 
linking sites are adjacent in the cross-linked protein. 
The membrane-bound G-protein coupled receptor (GPCR) bovine Rhodopsin 
(Rho) proved to be a suitable target for these studies because it contains 6 unmodified 
cysteines and 10 unmodified lysines (&6 and K67 adjacent) that are potential sites for 
lysine-cysteine (K-C) and lysine-lysine (K-K) cross-linking. Rho is the active form of 
the -40 kDa protein opsin (348 amino acids) that is modified by a retinal cofactor at K296. 
Following light-induced isomerization of 1 1 -cis-retinal to all-trans-retinal, Rho changes 
conformation and activates the vertebrate vision signaling pathway”. Membrane 
proteins, such as the GPCRs, are promising targets for MS3D because, despite their 
importance to human biology and the pharmaceutical industry, less than 90 membrane 
proteins have been resolved by X-ray crystallography and NMR spectroscopy2’. Non- 
traditional structural determination methods for membrane proteins, such as MS3D, that 
can overcome the challenges of resolving various PTMs, protein instability, and 
aggregation are therefore of great potential utility to current structural genomics efforts. 
Experiment a1 
Materials. Frozen bovine retinas were purchased from Schenk Packing 
Company, Inc. (Stanwood, WA). The cross-linking reagents, including disuccinimidyl 
suberate (DSS), N-succinimidyl iodoacetate (SIA), and N-(E-maleimidocaproloxy) 
succinimidyl ester (EMCS) were purchased from Pierce (Rockford, IL). 
Sample preparation. Bovine Rhodopsin (Rho) in the rod outer segment was 
cross-linked in its native state under dim red light using K-C and K-K cross-linkers. K-K 
cross-linking was achieved by reaction with DSS, and K-C cross-linking was achieved by 
reaction with SIA or EMCS. The cross-linking reaction was performed by adding 100 
fold molar excess of cross-linker in 50 mM pyridine buffer at pH 7 with 100 mM NaC1. 
Following the cross-linking reactions, samples were reduced with 50 mM tris(2- 
carboxyethy1)phosphine and alkylated with 1 50 mM 4-vinylpyridine. Monomeric Rho 
was separated from inter-molecular cross-linked species and contaminants by preparative 
PAGE using a miniprep cell (Bio-Rad, Hercules, CA). Purified Rho was precipitated and 
detergent was removed by chlorofonn/methanol/H~0 extraction. Rho was proteolyzed 
using 100-200 mM CNBr in 70% TFA under nitrogen overnight. Large cross-linked 
peptides containing adjacent lysines were purified by semi-preparative HPLC on a PLRP- 
S column (5pm, 300A, 2.Ox150mm, Michrom Bioresources) using Hewlett Packard 1100 
series LC system. The LC elution conditions were as follows (% v/v): solvent A = 
2.5:2.5:5:90 isopropanol/acetonitrile/acetic acid/water; solvent B = 50:40:4:6 
isopropanol/acetonitrile/acetic acid/water; the gradient method = 0 min - lOO%A, 5 min - 
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8O%A / 20%B, 50 min - 30%A / 70%B, 60 min - O%A / lOO%B, 70 min - O%A / 
lOO%B; flow rate = 0.3 mL/min. Eluent fractions were collected using a BioRad 21 10 
fraction collector. 
FT-MS/MS. Fractions containing cross-linked peptides were analyzed by direct 
infusion on an APEX I1 FTMS instrument equipped with a 7.0 T superconducting magnet 
and an Apollo electrospray ionization (ESI) ion source (Bruker Daltonics, Billerica, MA) 
upgraded with a mass selective quadrupole (Q) front end21. IRMPD was performed with 
a 25 W infrared C02 laser (Synrad, Model No. 48-2-2, Mukilteo, WA). ECD was 
performed with an indirectly heated cathode operated at 1.7 amps of heater current 
(Heatwave, Part No. 101 105, Crescent Valley, BC). The indirectly heated cathode was 
spot-welded in-house, directly on the standard Bruker Daltonics mounting flange for the 
internal filament, with no additional grids. Mass spectra were obtained with the QFTMS 
by accumulating ions in the ESI source hexapole and running the Q mass filter in non 
mass-selective RF-only mode so that ions of a broad m/z range (300-2000) were passed to 
the FTMS analyzer cell. The species of interest were isolated in the gas-phase by setting 
the Q mass filter to pass the m/z for ions of interest within a 3.5 m/z window. After a 
clean selection of the desired precursor ion had been confirmed, fragmentation was 
induced by: a) dropping the potential of the collision cell (CID); b) transferring the intact 
molecular ions to the analyzer cell and irradiating with a C02 laser (IRMPD); or c) 
transferring the intact molecular ions to the analyzer cell and irradiating with an electron 
beam (ECD). All MSMS spectra were acquired in the positive ion mode with 1M data 
points and 128 time-domain transients. Typical conditions for fragmentation of the 
pentuply charged cross-linked peptide a-XL-P 1 include: dropping the collision cell 
potential to -24.5 V for CID, irradiating for 50 msec with a 25 W C02 laser run at 35% 
of full power for IRMPD, and pulsing the electron energy to a value of -5 V with an 
irradiation time of 3.5 msec for ECD (at all other times the electron emitting surface was 
biased to +I 5 V to prevent electrons from being emitted toward the analyzer cell). 
Automated data-reduction and assignment of the fragmentation spectra were performed 
by an in-house macro6 and software package (MS2Links) ', 2, respectively. Peaks in the 
MSMS spectra are labeled by the most probable ion assignments; however, inter-residue 
cleavage sites were deduced solely by unambiguous ion assignments. 
Results and Discussion 
Proteolysis and MS. Cleavage of membrane proteins by chemical or enzymatic 
methods can be challenging due to the poor reaction conditions (low pH, detergent, 
and/or high organic) required for solubility and the poor recovery of hydrophobic 
peptides in more favorable conditions. In-gel trypsin digestion of Rho cleaved the bond 
between I(66 and K67, but a poor yield and/or recovery of tryptic peptides and missed 
cleavages were observed (data not shown). These problems have often been reported for 
tryptic digests; therefore, we investigated CNBr for proteolysis of Rho at conditions 
optimal for protein solubility (low pH and high organic). Complete CNBr digestion of 
Rho should yield 9 large peptides (2-6 kDa) and 6 small peptides (0.4- 1.4 kDa) following 
C-terminal cleavage at 16 methionines. In-solution CNBr digestion of purified cross- 
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linked monomers produced 9 large peptides and 6 small peptides with 100% sequence 
coverage, few missed cleavages, and good yield as expected (data not shown). 
acid residues for K-C and K-K cross-linking based on the dark-adapted structure for 
Rho” (i.e., unmodified residues on the intra-cellular face of Rho) and residue-specific 
accessibility studies (data not shown). There are 27 possible K-C cross-links (Le., KCC 
where K=9 and C=3) and 36 possible K-K cross-links (i.e., CK-1 where K=9) for singly 
cross-linked Rho. Cross-links with only 1 of 2 adjacent lysines (&6 or I(67) can be 
expected to be particularly difficult to assign unambiguously. 
and CNBr proteolysis, new peptides were observed and identified as cross-linked pairs of 
CNBr peptides. However, several CNBr peptides contained more than one K residue, 
making unambiguous assignment of the residues involved in the cross-link impossible. 
One CNBr peptide was particularly problematic. This 37-aa peptide, RhO50-86, contains 2 
adjacent lysines (K66 and K67) and was found to form cross-links with two other peptides. 
Subsequent digestion of these large cross-linked peptides with trypsin, which cleaves at 
K and R residues, was hindered by poor solubility. Moreover, CNBr digests (and double 
digests with CNBr + trypsin) failed to cleave the bond between K66 and K67. Therefore, 
large cross-linked peptides containing K66 and G7 were analyzed by FT-MS/MS. 
FT-MS/MS. Cross-linked peptides formed from two large peptides (a at 
4240.4185 Da and p2 at 3598.9348 Da) containing 2 lysines each, and one small peptide 
(p 1 at 99 1.4663 Da) containing 1 cysteine, were fragmented by CID, IRMPD, and ECD. 
Annotation of the cross-linked peptides as a- and p- chains was described previously2. 
Figure 1 shows that Rhoso-86 (a) contains 2 adjacent lysines (K66 and I(67) and 2 possible 
K-C cross-links when cross-linked with Rho310-317 (pl)  at c316. Likewise, there are 4 
possible K-K cross-links when Rh050-86 (a)  is cross-linked to Rho318-348 (p2) at K325 
andor K339. In the latter pair, both chains are large and contain two K residues each, 
making unambiguous assignment of the points of cross-link attachment especially 
difficult. In either case, a-XL-PI or a-XL-P2, where XL is the cross-linker, cleavage of 
the bond between K66 and &7 in a is the most critical for unambiguous assignment of 
intra-molecular cross-links. Note that the methionines at sequence positions 86 and 3 17 
are converted to homo-serine lactones, because of the cyanogen bromide digestion used 
in this work. 
a-XL-pl. CID and IRMPD of the sextuply charged cation [M+EMCS+6HI6+ at 
905.1676 m/z (Am = 0.6 ppm) from the cross-linked peptide a-EMCS-Dl (5424.9587 Da) 
yielded abundant b- and y-type ions (Figures 2A and 2B), respectively. Sequence-specific 
identification of cross-linked peptides such as this improves confidence in cross-link 
assignments. However, the product ion spectra were complicated by numerous internal 
fragment ions and cleavage between K66 and I(67 was never observed. Based on our CID 
and IRMPD results, we are unable to determine whether &6 or I(67 is cross-linked to 
Cross-linking. Nine of 11 lysines (K) and 3 of 6 cysteines (C) are possible amino 
Following chemical cross-linking of Rho using various K-K or K-C cross-linkers 
c316-  
ECD of the [M+EMCS+6HI6+ ion yielded abundant c- and z-type ions with few 
internal fragment ions (Figure 3A). Likewise, ECD of the sextuply charged cation 
[M+SIA+6HI6+ at 879.6533 m/z (Am = 0.7 ppm) from the cross-linked peptide a-SIA-PI 
(5271.8797 Da) provided extensive backbone fragmentation (Figure 3B). ECD of the 
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pentuply charged cation [M+5HI5+ for the control (unmodified) peptide a at 849.0904 
m/z (Am = 0.7 ppm, 4240.4185 Da) is shown in Figure 3C. Cleavage of the bond between 
I(66 and K67 was observed in every case. Thus, ECD revealed that K67 (and not K66) is 
cross-linked to C316. This was clearly demonstrated by comparing the ECD spectrum for 
control peptide a (Figure 3C) with the ECD spectra for cross-linked peptides (Figures 
3A-B). Figure 3C shows the presence Of ~ 1 7 ~  and ~ 2 l a  ions for &6 and ~ 1 8 ~  and z20a ions 
for I(67. However, the C18a and z20a ions are replaced by Cl8a+MP and Z20a+Mp ions in 
Figures 3A-B (where Mp = XL+p1, pl  = 991.4663 Da, and XL = 193.0739 Da for EMCS 
or 39.9949 Da for SIA). N-terminal cleavage at prolines was never observed by ECD, as 
expectedI4, 16. While complementary sequence-specific information was obtained by 
combining cross-link assignments for a-XL-PI from CID, IRMPD, and ECD, only ECD 
spectra contained crucial c- and z-ions resulting from cleavage of the bond between I(66 
and I(67. 
a-XL-P2. Rho, like most mammalian membrane proteins, contains several PTMs 
that further compound the problem of unambiguously assigning intra-molecular chemical 
cross-links to specific amino acid residue(s). However, ECD of the septuply charged 
cation [M+DSS+7HI7+ at 1140.6378 m/z (Am = 1 .O ppm) from the cross-linked peptide 
a-DSS-P2 (7977.42 14 Da) revealed full palmitoylation of adjacent cysteines (c322 and 
c323) and cross-linking of I(67 (and not I(66) with K325 and K339 (Figure 4). Consistent 
with the nonergodic ECD mechanism and a previous study on grehlin with an unusual 
fatty acid modification22, the palmitoyl groups were retained on all c- and z-ions that 
contained C322 and c323. The ECD spectrum in Figure 4 shows the presence of the 
unmodified C17a ion for &6, the absence of the unmodified ~ 1 8 ~  ion for K67, and the 
presence of the cross-linked and doubly-palmitoylated C2NMp ion containing both I(66 and 
&7 (where Mp = XL+f32, f32 = 3598.9348 Da, and XL = 138.0681 Da for DSS). No 
unmodified z20a and z21a ions or cross-linked z20+ Mp and z21+ ~p ions were observed. 
Based on this evidence, G7 (and not I(66) is involved in cross-linking with K325 andor 
K339. No fragments were generated from cleavage between K325 and K339 on the p2 chain 
either; however, the presence of doubly-palmitolyated (and not cross-linked) c- and z- 
ions suggests that both K325 and K339 were cross-linked. While alternative explanations 
for these observations exist (i.e., doubly-palmitoylated fragments could possibly be 
formed from 2 bond cleavages of the corresponding cross-linked peptides), it is highly 
unlikely that these cross-link assignments are incorrect. 
links with only 1 of 2 adjacent lysines (I(67 and not I(66) will form with c316, K325, and 
K339. For example, the cross-linking reaction between G7 to c316 could begin with the 
attachment of the maleimide (EMCS) or iodo (SIA) group of the cross-linker to the thiol 
group of C316 followed by attachment of the succinimidyl ester end of the cross-linker to 
the &-amino group of 1 6 7 .  Studies of cross-link formation as a function of distance, cross- 
linker flexibility, protein conformation, and reactivity are currently underway. However, 
based on a 40 ns molecular dynamics trajectory of Rho with explicit lipid bilayer in 
solvent, the calculated average solvent accessibility of I(67 is -3-fold greater than &6 23. 
Furthermore, alkylation experiments of Rho in lipid bilayers show that only one lysine in 
peptide a is reactive with 50X NHS-acetate and only -75% is fully akylated (both 
lysines) even in the presence of 1OOOX NHS-acetate (data not shown). Finally, I(66 vs. 
Comparison with Known Structure. The previous discussion shows that cross- 
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K67 distances to C316 are 13.1 vs. 9.2 A and 11.0 vs. 9.9 A for the X-ray ~tructure '~ and 
molecular dynamics trajectorie~~~, respectively. While we cannot know the relative 
contribution of reactivity vs. distance from this information, and other factors may 
contribute to the rates of cross-link formation at K66 and K67, the solvent accessibility 
information and distances from the known structure are consistent with our results that 
show only K66 participates in cross-linking reactions. 
Fragmentation of Cross-Linked Peptides. Different fragmentation mechanisms 
for bonds involving the cross-linker for a-SIA-Pl and a-EMCS-PI are suggested by their 
ECD spectra (Figures 3A-B). Bond cleavages observed by ECD are shown in Figure 5 
where the frequency of cleavage at sites 1-111, deduced from the relative abundance of 
ions formed from cleavage at each site, is indicated by the size of the lightning bolt (not 
to scale). Major fragmentation of the cross-links occurs at cleavage sites I1 for EMCS and 
I1 and I11 for SIA. This corresponds to cleavage on either side of sulfur, suggesting that 
sulfur could be a hydrogen acceptor that directs fragmentation. Evidence for this is found 
by the observation that cleavage adjacent to the electron withdrawing succinimide group 
at site I1 in EMCS (Figure 5A) is more pronounced than cleavage at site I1 in SIA (Figure 
5B). Minor peaks in the ECD spectra, products of selective accumulation in the collision 
cell, appear as b- and y-type ions from cleavage at site I. While these observations may 
prove useful for unambiguous assignment of chemical cross-links, it is clear that the 
fragmentation mechanisms of cross-linked peptides merit further study. 
Conclusions 
This work effectively demonstrates unambiguous assignment of intra-molecular 
chemical cross-links to specific amino acid residue(s), when two or more possible cross- 
linking sites are adjacent in the cross-linked protein, by FT-MSMS. To our knowledge 
this work also presents the first demonstration that ECD can be used to characterize S- 
linked fatty acid acylation on cysteines. The impact of incorrect (or ambiguous) intra- 
molecular cross-link assignments on models of the tertiary structure of a cross-linked 
protein is expected to be significant. Likewise, the impact of incorrect (or ambiguous) 
inter-molecular cross-link assignments on protein complex topology and protein-protein 
interactions may also be significant. Therefore, the comprehensive fragmentation of 
large, multiply-charged, peptides by CID, IRMPD, and particularly ECD, in conjunction 
with the high resolution and mass accuracy of FT-MSMS, is expected to be a valuable 
means of characterizing even difficult proteins such as mammalian membrane proteins 
with both chemical- and post-translational modifications. 
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Figures 
Figure 1. Sequences of cross-linked Rho peptides. Rh050-86 (a) contains 2 adjacent 
lysines, I(67 and &8, and 2 possible K-C cross-links when cross-linked with Rho 310- 
317 (pl) at c316. Likewise, there are 4 possible K-K cross-links when Rho50-86 (a) is 
cross-linked to Rho318-348 (p2) at K325 or K339. Annotation of the cross-linked peptides 
as a- and p- chains was described previously2. Note that the methionines at 
sequence positions 86 and 317 are converted to homo-serine lactones, because of the 
cyanogen bromide digestion used in this work. 
a: 
P I :  
a: 
p2: 
5 LGFPINFLTLYVTVQH KKLRTPLNYILLNLAVADLFM 8 
31 NKQFRNcM31 
5 LGFPINFLTLYVTVQH KK LRTPLNYILLNLAVADLFM n 
31 VTTLCCGK NPLGDDEASTTVSxTETSQVAPA34 
I I  
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Figure 2. CID and IRMPD of the sextuply charged cation [M+EMCS+6HI6+ at 
905.1676 m/z (Am = 0.6 ppm) from the cross-linked peptide a-EMCS-Pl (5424.9587 
Da) yielded abundant b- and y-type ions (Figures 2A and 2B), respectively. 
However, the product ion spectra were complicated by numerous internal ions and 
cleavage between I<67 and I(68 was never observed. 
Fig 2A: CID of a-EMCS-Pl 
bO1 6-23a 
- 
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Fig 2B: IRMPD of a-EMCS-Pl 
111 111111 1 111111111 
LL LLLL L L LL 
50LG F P I N FLTLWTVQH KK L R?PL l?Y I LL N LAVAD LF M 86 a 3a 
3l0NKQFRNGM3l7 
e 
1 4 .  AA-U-L-I..--L---Y- 
200 600 1000 1400 1800 2200 2600 
Y34a Y35a 
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Figure 3. ECD of the [M+EMCS+6H]6+ ion yielded abundant c- and z-type ions 
with few internal fragment ions (Figure 3A). Likewise, ECD of the sextuply charged 
cation [M+SIA+6H]6+ at 879.6533 m/z (Am = 0.7 ppm) from the cross-linked 
peptide a-SIA-Pl (5271.8797 Da) provided extensive backbone fragmentation 
(Figure 3B). ECD of the pentuply charged cation [M+5H]5+ for the control peptide 
a at 849.0904 m/z (Am = 0.7 ppm, 4240.4185 Da) is shown in Figure 3C. Cleavage of 
the bond between K66 and K67 was observed in every case. 
Fig 3A: ECD of a-EMCS-P1 
111111 1 n-t-ni i i i i i i i i i  
50LGFPINFLTLWTVQH KKLRTPLiYlLLNLAVADLFM B6 
LL LL LLLLLLLLL 
400 800 1200 1600 2000 2400 
Fig 3B: ECD f a-SIA-Pl 
1111111111 11 111 1 1  111 1111 
50LGFP I N FLTLWTVQH KK LRTPLNY I LLN LAVADLFM 86 
L LL LLLLLLLLLLLLLL L \ 
111% 
310NKQFRNCM317 
LL 
--- 
2200 
C36a 
C a  1800 4 
600 1000 1400 
Fig 3C: ECD of control a 
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Figure 4. ECD of the septuply charged cation [M+DSS+7HI7+ at 1140.6378 d z  (Am 
= 1.0 ppm) from the cross-linked peptide a-DSS-P2 (7977.4214 Da) revealed full 
palmitoylation of adjacent cysteines (C322 and C323) and cross-linking of &7 (and not 
&6) to K325 and K339- 
.." i inniiiii i "::
L.. L L /.. ..... 50LG F P I N FLTLWTVQH KK LRTP L NY I L L izAVA6 L FW6 .... 
in i i -I/i-: 1."" I...... 7 
VTTLCCGE NPLGDDEASTTVSKTET&A?A 
4 &  L LLLL LLL L E L L  
. 
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Figure 5. Bond cleavages observed by ECD for (A) a-EMCS-Pl and (B) a-SIA-Pl. 
The frequency of cleavage at sites 1-111, deduced from the relative abundance of ions 
formed from cleavage at each site, is indicated by the sue of the lightning bolt (not 
to scale). 
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